Clinical laboratory testing for covid-19 at brian d. Allgood army community hospital, usameddac-korea

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0220D0017
Awardee
Awarding agency
Task orders
2 $9,805,900 obligated

Award facts

Combined order value
$9,805,900 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 86% used
$11,354,200.00
Award type
Single award
Who can order
Only the awarding agency
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
6 offers Simplified Acquisition
Pricing
Firm Fixed Price
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

About this IDV

The Department of the Army Medical Command awarded a single-award Indefinite Delivery Contract valued at $11.35 million to Seoul Clinical Laboratories, a South Korean clinical laboratory and diagnostic testing provider, to supply COVID-19 clinical laboratory testing services at Brian D. Allgood Army Community Hospital under United States Army Medical Command-Korea (USAMEDDAC-Korea). The contract, awarded October 1, 2020, with an ultimate completion date of September 30, 2025, was designated under the Coronavirus COVID-19 National Interest Action Code and included no small business set-aside. Seoul Clinical Laboratories, registered in the System for Award Management since 2006 and headquartered in Yongin-si, Gyeonggi-do, South Korea, performed all laboratory testing services at its South Korea facility to support the Army medical treatment facility's COVID-19 diagnostic testing requirements for service members and authorized patients.

Two delivery orders were issued against this indefinite delivery contract vehicle. The first delivery order, awarded October 1, 2020, with a ceiling value of $6.71 million and completion date of September 30, 2021, provided clinical laboratory testing services on a firm-fixed-price basis with excess funds subsequently de-obligated. The second delivery order, awarded October 1, 2021, valued at $3.10 million with a completion date of June 8, 2022, continued COVID-19 testing support under firm-fixed-price terms and was terminated for the government's convenience. Both delivery orders operated without subcontractor involvement or set-aside designations, delivering essential diagnostic testing capabilities to support United States military healthcare operations in the Pacific region during the COVID-19 pandemic response.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00005 · Clinical laboratory testing for covid-19 at brian d. Allgoood army community hospital, usameddac-korea. Reallocate quantity from slin 0001AC to 0001AB. $0
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract W81K0220D0017?

W81K0220D0017 was awarded to Seoul Clinical Laboratories by Medical Command (Department of the Army) on October 1, 2020.

How much is contract W81K0220D0017 worth?

Orders under W81K0220D0017 have obligated $9,805,900. W81K0220D0017's own ceiling is $11,354,200.

How many orders have been placed under contract W81K0220D0017?

2 orders have been placed under W81K0220D0017, the latest on October 1, 2021.

Who can order from contract W81K0220D0017?

W81K0220D0017 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0220D0017 competed?

The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV